Evaluates antibacterial activity of new isoxazoline compounds, suggesting promising pathways for treatment.
Novel mono- and bis-isoxazoline compounds were synthesized and showed strong antibacterial activity. Network pharmacology highlights key pathways involved, and supported by docking and molecular dynamics, confirming stable target binding.
No takes yet. Share an insight, caveat, or question.
Altharawi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: